S, B., AS, G., PG, B., AK, Y., & RK, S. (2026). Montelukast attenuated memory decline, neuroinflammatory and neurodegenerative biomarkers in Aβ1-42 exposed model of alzheimer's disease in mice. Psychopharmacology, 243(3), 601. https://doi.org/10.1007/s00213-025-06865-0
Chicago Style (17th ed.) CitationS, Balki, Gautam AS, Balaji PG, Yadav AK, and Singh RK. "Montelukast Attenuated Memory Decline, Neuroinflammatory and Neurodegenerative Biomarkers in Aβ1-42 Exposed Model of Alzheimer's Disease in Mice." Psychopharmacology 243, no. 3 (2026): 601. https://doi.org/10.1007/s00213-025-06865-0.
MLA (9th ed.) CitationS, Balki, et al. "Montelukast Attenuated Memory Decline, Neuroinflammatory and Neurodegenerative Biomarkers in Aβ1-42 Exposed Model of Alzheimer's Disease in Mice." Psychopharmacology, vol. 243, no. 3, 2026, p. 601, https://doi.org/10.1007/s00213-025-06865-0.